Multiple broad cellular targets

Multiple broad cellular targets is a descriptive term used in pharmacology to categorize therapeutic agents that exert their biological effects through interactions with a wide variety of molecular structures rather than a single, well-defined protein or receptor. This classification is often associated with polypharmacology, a strategy where a drug is designed or discovered to hit multiple targets to achieve a synergistic therapeutic effect, particularly in complex diseases like cancer or psychiatric disorders (Nature Reviews Drug Discovery, 2012). For example, many traditional cytotoxic chemotherapies, such as alkylating agents, fall into this category because they react with DNA, RNA, and various proteins across the entire cell (CA: A Cancer Journal for Clinicians, 2011). While hitting multiple targets can prevent the development of drug resistance by blocking redundant signaling pathways, it significantly increases the complexity of predicting pharmacokinetics and pharmacodynamics. The lack of specificity inherent in targeting multiple broad cellular components often leads to a higher incidence of systemic toxicity and off-target adverse effects (Pharmacological Reviews, 2019). Consequently, in drug discovery and regulatory filings, this term indicates that the compound's mechanism is pleiotropic or that its specific molecular interactome has not been fully deconvoluted.

Other names

Multi-targetNon-specific targetsPleiotropic targetsPolypharmacological targetsBroad-spectrum cellular targets

Simultaneous modulation of multiple signaling pathways, enzymes, or structural cellular components such as nucleic acids and lipid membranes.